Abstract
There are still considerable differences in the medication supply for men and women. While the prescription volumes for both men and women have, for some time, been similar or have even risen for the men, there are still characteristic differences between the sexes when it comes to the prescription of certain indication groups. Women are still prescribed clearly more drugs in the field of psychotropic medication, especially antidepressants, hypnotic drugs, and tranquilisers. As the American Beers criteria for quite some time now and, more recently, the German PRISCUS list have shown, the effects of such drugs are potentially dangerous, particularly for older women. The known adverse effects are, apart from dependence problems, restricted cognitive capacities, insecure or instable walking, and badly healing wounds from falling accidents that are followed by patient’s nursing care dependency. In secondary prophylaxis after acute myocardial infarction, the characteristic prescription features of the various medicinal products that are used for both men and women (such as platelet aggregation inhibitors, beta-receptor blockers, ACE-inhibitors, statins) have become similar; women’s still higher mortality risk appears to go back to the fact that too much time is spent before proper hospital treatment commences. In general, more attention should be paid to the right medication, the right length of treatment, and the right dosage of the medication prescribed to women; the evidence concerning women’s supply of medicinal products should also be improved.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Abbreviations
- DDD:
-
Defined daily doses
- SSRI:
-
Selective serotonin reuptake inhibitor
- NSMRI:
-
Non-selective monoamine reuptake inhibitor
- ATC Code:
-
Anatomical therapeutic chemical classification system (WHO)
- ICD-10:
-
International statistical classification of diseases and related health problems (WHO)
- Rx:
-
Prescription only drug
List of references
Coca V, Nink K (2011) Arzneiverordnungen nach alter und geschlecht. In: Schwabe U, Paffrath D (eds) Arzneiverordnungs-Report 2011. Springer, Heidelberg, Berlin
Cumming RG, Le Couteur DG (2003) Benzodiazepines and risk of hip fractures in older people: a review of the evidence. CNS Drugs 7:825–837
Fick DM, Cooper JW, Wade WE, Waller JL, Maclean JR, Beers MH (2003) Updating the Beers criteria for potentially inappropriate medication use in older adults: results of a US consensus panel of experts. Arch Intern Med 163:2716–2724
Franke A, Elsesser K, Sitzler F, Algermissen G, Kötter S (1998) Gesundheit und Abhängigkeit bei Frauen: Eine salutogenetische Verlaufsstudie. Runge, Cloppenburg
Glaeske G (2002) Geschlechtsspezifische Inanspruchnahme des Versorgungssystems. In: Hurrelmann K, Kolip P (eds) Geschlecht, Gesundheit und Krankheit. Männer und Frauen im Vergleich. Huber, Bern
Glaeske G (2011) Psychotrope und andere Arzneimittel mit Abgängigkeitspotenzial. In: Deutsche Hauptstelle für Suchtfragen (DHS) (ed) Jahrbuch Sucht 2011. Geesthacht, Neuland, pp 165–188
Glaeske G, Janhsen K (2006) GEK-Arzneimittelreport 2006. Asgard, St. Augustin
Glaeske G, Schicktanz C (2011) BARMER GEK Arzneimittelreport 2011. Asgard, St. Augustin
Herings RM, Stricker BH, de Boer A, Bakker A, Sturmans F (1995) Benzodiazepines and the risk of falling leading to femur fractures. Dosage more important than elimination half-life. Arch Intern Med 155:1801–1807
Hippisley-Cox J, Pringle M, Crown N, Meal A, Wynn A (2001) Sex inequalities in ischaemic heart disease in general practice: cross sectional survey. BMJ 322:1–5
Hoffmann F, Glaeske G (2006) Neugebrauch von Benzodiazepinen und das Risiko einer proximaler Femurfrakturen. Eine case-crossover studie. Z Gerontol Geriat 39:143–148
Hoffmann F, Glaeske G, Scharffetter W (2006) Zunehmender Hypnotikagebrauch auf Privatrezepten in Deutschland. Sucht 52:360–366
Hoffmann F, Scharffetter W, Glaeske G (2009) Verbrauch von Zolpidem und Zopiclone auf Privatrezepten zwischen 1993 und 2007. Nervenarzt 80:578–583
Hoffmann F, Hies M, Glaeske G (2010) Regional variations of private prescriptions for non-benzodiazepine hypnotics zolpidem and zopiclone in Germany. Pharmacoepidemiol Drug Saf 19:1071–1077
Holt S, Schmiedl S, Thürmann PA (2010) Potenziell inadäquate Medikation für ältere Menschen: Die PRISCUS-Liste. Dtsch Arztebl Int 107:543–551
Leipzig RM, Cumming RG, Tinetti ME (1999) Drugs and falls in older people: a systematic review and meta-analysis: I. Psychotropic drugs. J Am Geriatr Soc 47:30–39
Löwel H, Meisinger C, Heier M et al (2002) Geschlechtsspezifische Trends von plötzlichem Herztod und akutem Herzinfarkt. Ergebnisse des bevölkerungsbasierten KORA/MONICA-Augsburg Herzinfarkt-Registers 1985–1998. Dtsch Med Wochenschr 127:2311–2316
Madhusoodanan S, Bogunovic OJ (2004) Safety of benzodiazepines in the geriatric population. Expert Opin Drug Saf 3:485–493
Mort JR, Aparasu RR (2002) Prescribing of psychotropics in the elderly: why is it so often inappropriate? CNS Drugs 16:99–109
Olsson G, Wikstrand J, Warnold I, Manger CV, McBoyle D, Herlitz J, Hjalmarson A, Sonneblick EH (1992) Metoprolol-induced reduction in postinfarction mortality: pooled results from five double-blind randomized trials. Eur Heart J 13:28–32
Ray WA, Griffin MR, Downey W (1989) Benzodiazepines of long and short elimination half-life and the risk of hip fracture. JAMA 262:3303–3307
Seeland U, Regitz-Zagrosek V (2012) Sex and gender differences in cardiovascular drug therapy. In: Regitz-Zagrosek V (ed) Sex and gender differences in pharmacology. Springer, Heidelberg
Statistisches Bundesamt (2012) DeSTATIS. Lebenserwartung in Deutschland. https.//www.destatis.de
Theres H, Maier B, Matteucci Gothe R et al (2004) Influence of gender on treatment and short-term mortality of patients with acute myocardial infarction in Berlin. Z Kardiol 93:954–963
Thürmann PA, Haack S, Werner U, Szymanski J, Haase G, Drewelow B, Reimann IR, Hippius M, Siegmund W, May K, Hasford J (2006) Tolerability of beta-blockers metabolized via cytochrome P450 2D6 is sex-dependent. Clin Pharmacol Ther 80:551–553
Wagner AK, Zhang F, Soumerai SB, Walker AM, Gurwitz JH, Glynn RJ, Ross-Degnan D (2004) Benzodiazepine use and hip fractures in the elderly: who is at greatest risk? Arch Intern Med 164:1567–1572
Walle T, Byington RP, Furberg CD, McIntyre KM, Vokonas PS (1985) Biologic determinants of propranolol disposition: results from 1308 patients in the beta-blocker heart attack trial. Clin Pharmacol Ther 38:509–518
Wang PS, Bohn RL, Glynn RJ, Mogun H, Avorn J (2001) Hazardous benzodiazepine regimens in the elderly: effects of half-life, dosage, and duration on risk of hip fracture. Am J Psychiatry 158:892–898
WIdO – Wissenschaftliches Institut der AOK (2012) Ältere Frauen erhalten besonders häufig ungeeignete Arzneimittel. Berlin, 23.März 2012
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer-Verlag Berlin Heidelberg
About this chapter
Cite this chapter
Glaeske, G., Gerdau-Heitmann, C., Höfel, F., Schicktanz, C. (2013). “Gender-Specific Drug Prescription in Germany” Results from Prescriptions Analyses. In: Regitz-Zagrosek, V. (eds) Sex and Gender Differences in Pharmacology. Handbook of Experimental Pharmacology, vol 214. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-30726-3_8
Download citation
DOI: https://doi.org/10.1007/978-3-642-30726-3_8
Published:
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-30725-6
Online ISBN: 978-3-642-30726-3
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)